Northwestern Mutual Wealth Management’s Neumora Therapeutics NMRA Stock Holding History
Bought
Maintained
Sold
Other funds holding NMRA
SL
VCM
MCMU
WT
IC
LC
JJ
Northwestern Mutual Wealth Management's NMRA Position: Q2 2026 in Review
Northwestern Mutual Wealth Management held its Neumora Therapeutics (NMRA) position steady in Q2 2026 at 76,706 shares worth $130K. The position accounts for ﹤0.01% of the portfolio, ranked #2167.
Northwestern Mutual Wealth Management first reported a position in NMRA in Q4 2024 and has held it in 7 quarters since. The position peaked at $813K in Q4 2024. 68 funds tracked by Wall St. Rank hold NMRA as of Q2 2026.
- Northwestern Mutual Wealth Management held 76,706 shares of Neumora Therapeutics worth $130K as of Q2 2026.
- Northwestern Mutual Wealth Management left its Neumora Therapeutics share count unchanged in Q2 2026.
- Neumora Therapeutics made up ﹤0.01% of Northwestern Mutual Wealth Management's portfolio in Q2 2026, its #2167 holding.
- Northwestern Mutual Wealth Management first reported a position in Neumora Therapeutics in Q4 2024 and has held it in 7 quarters since.
- Northwestern Mutual Wealth Management's Neumora Therapeutics position peaked at $813K in Q4 2024.
- 68 funds tracked by Wall St. Rank held Neumora Therapeutics as of Q2 2026.
Based on Northwestern Mutual Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.